Tocilizumab treatment in COVID-19: A prognostic study using propensity score matching

Ö Güçlü, U Önal, E Akalın, N Öztürk… - … IN CLINICAL AND …, 2022 - avesis.uludag.edu.tr
Background. The potential role of interleukin-6 (IL-6) in coronavirus disease 2019 (COVID-
19) pneumonia provides the rationale for investigating IL-6 signaling inhibitors. Objectives …
被引用次数：1 相关文章
[HTML] umw.edu.pl

[HTML][HTML] Tocilizumab treatment in COVID-19: A prognostic study using propensity score matching

ÖA Güçlü, U Önal, H Akalın, NAA Öztürk, HÖ Belik… - advances.umw.edu.pl
Background. The potential role of interleukin-6 (IL-6) in coronavirus disease 2019 (COVID-
19) pneumonia provides the rationale for investigating IL-6 signaling inhibitors. Objectives …

Tocilizumab treatment in COVID-19: A prognostic study using propensity score matching.

Ö Aydın Güçlü, U ÖnalA, H Akalın… - … in Clinical & …, 2022 - search.ebscohost.com
Background. The potential role of interleukin-6 (IL-6) in coronavirus disease 2019 (COVID-
19) pneumonia provides the rationale for investigating IL-6 signaling inhibitors. Objectives …

Tocilizumab treatment in COVID-19: A prognostic study using propensity score matching

ÖA Güçlü, U Önal, H Akalın… - … in clinical and …, 2022 - pubmed.ncbi.nlm.nih.gov
Background The potential role of interleukin-6 (IL-6) in coronavirus disease 2019 (COVID-
19) pneumonia provides the rationale for investigating IL-6 signaling inhibitors. Objectives …